These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1874755)

  • 21. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
    Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A
    J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival.
    Groves HM; Kinlough-Rathbone RL; Richardson M; Jørgensen L; Moore S; Mustard JF
    Lab Invest; 1982 Jun; 46(6):605-12. PubMed ID: 7087391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial.
    Heyworth BE; Lee JH; Kim PD; Lipton CB; Strauch RJ; Rosenwasser MP
    J Hand Surg Am; 2008 Jan; 33(1):40-8. PubMed ID: 18261664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-linked hyaluronan (Hylan B gel): a new injectable remedy for treatment of vocal fold insufficiency--an animal study.
    Hallén L; Johansson C; Laurent C
    Acta Otolaryngol; 1999 Jan; 119(1):107-11. PubMed ID: 10219396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of blood coagulation activity on the transmural potential of vessel walls].
    Markosian AA; Chepurov AK
    Fiziol Zh SSSR Im I M Sechenova; 1970 Oct; 56(10):1451-6. PubMed ID: 5502682
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinous tissue glue in artery anastomosis. Physiological, histological and scanning evaluation.
    Decleer W; Vanhove M; Coenen L; Boeckx W; Gruwez JA
    Acta Chir Belg; 1985; 85(2):121-4. PubMed ID: 3874507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility of injectable chitosan-phospholipid implant systems.
    De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
    Biomaterials; 2009 Aug; 30(23-24):3818-24. PubMed ID: 19394688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of glans penis using injectable hyaluronic acid gel.
    Moon DG; Kwak TI; Cho HY; Bae JH; Park HS; Kim JJ
    Int J Impot Res; 2003 Dec; 15(6):456-60. PubMed ID: 14671667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
    Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
    Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of fortified fibrin/hyaluronic acid composite gel as a cell delivery vehicle for chondrocytes.
    Park SH; Cui JH; Park SR; Min BH
    Artif Organs; 2009 Jun; 33(6):439-47. PubMed ID: 19473139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lubrication and wear properties of grafted polyelectrolytes, hyaluronan and hylan, measured in the surface forces apparatus.
    Benz M; Chen N; Israelachvili J
    J Biomed Mater Res A; 2004 Oct; 71(1):6-15. PubMed ID: 15368250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-molecular-weight hyaluronan inhibits macrophage proliferation and cytokine release in the early wound of a preclinical postlaminectomy rat model.
    Schimizzi AL; Massie JB; Murphy M; Perry A; Kim CW; Garfin SR; Akeson WH
    Spine J; 2006; 6(5):550-6. PubMed ID: 16934726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces.
    Jordan O; Doelker E; Rüfenacht DA
    Cardiovasc Intervent Radiol; 2005; 28(5):561-9. PubMed ID: 15959697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
    Pelletier JP; Martel-Pelletier J
    J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the changes in blood coagulation factors through parenteral administration of cobalt(II) compounds in rabbits].
    Wohllebe W; Taube C; Fiedler H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 89(3):315-21. PubMed ID: 4176081
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytocompatible gel formation of chitosan-glycerol phosphate solutions supplemented with hydroxyl ethyl cellulose is due to the presence of glyoxal.
    Hoemann CD; Chenite A; Sun J; Hurtig M; Serreqi A; Lu Z; Rossomacha E; Buschmann MD
    J Biomed Mater Res A; 2007 Nov; 83(2):521-9. PubMed ID: 17503494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homologous controlled-viscosity fibrin for endovascular embolization. Part II: catheterization technique, animal experiments.
    Richling B
    Acta Neurochir (Wien); 1982; 64(1-2):109-24. PubMed ID: 7124468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix engineering.
    Balazs EA; Bland PA; Denlinger JL; Goldman AI; Larsen NE; Leshchiner EA; Leshchiner A; Morales B
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):173-8. PubMed ID: 1772987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow potential of the rabbit aorta.
    Ermolaev YuA ; Markosyan RA
    Bull Exp Biol Med; 1974 Aug; 77(2):98-100. PubMed ID: 4433932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.